A piece of the tumor was made completely transparent and scanned in 3D with a special microscope. The components labeled with fluorescent colors were rendered in a rotatable 3D representation on the computer (red: blood vessels, turquoise: tumor cells, yellow: therapeutic antibody).
CREDIT: Plückthun Lab
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold the solution to better delivery of Covid-related therapies directly to the lungs.
Scientists at the University of Zurich have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics directly into tumor cells. Unlike chemotherapy or radiotherapy, this approach does no harm to normal healthy cells. Once inside tumor cells, the delivered genes serve as a blueprint for therapeutic antibodies, cytokines and other signaling substances, which are produced by the cancer cells themselves and act to eliminate tumors from the inside out.
Sneaking adenoviruses past the immune system undetected
“We trick the tumor into eliminating itself through the production of anti-cancer agents by its own cells,” says postdoctoral fellow Sheena Smith, who led the development of the delivery approach. Research group leader Andreas Plueckthun explains: “The therapeutic agents, such as therapeutic antibodies or signaling substances, mostly stay at the place in the body where they’re needed instead of spreading throughout the bloodstream where they can damage healthy organs and tissues.”
The UZH researchers call their technology SHREAD: for SHielded, REtargetted ADenovirus. It builds on key technologies previously engineered by the Plueckthun team, including to direct adenoviruses to specified parts of the body to hide them from the immune system.
High amount of drugs in the tumor, low concentration in other tissues
With the SHREAD system, the scientists made the tumor itself produce a clinically approved breast cancer antibody, called trastuzumab, in the mammary of a mouse. They found that, after a few days, SHREAD produced more of the antibody in the tumor than when the drug was injected directly. Moreover, the concentration in the bloodstream and in other tissues where side effects could occur were significantly lower with SHREAD. The scientists used a very sophisticated, high-resolution 3D imaging method and tissues rendered totally transparent to show how the therapeutic antibody, produced in the body, creates pores in blood vessels of the tumor and destroys tumor cells, and thus treats it from the inside.
Use to combat Covid-19 being investigated
Plueckthun, Smith and colleagues emphasize that SHREAD is applicable not only for the fight against breast cancer. As healthy tissues no longer come into contact with significant levels of the therapeutic agent, it is also applicable for delivery of a wide range of so-called biologics – powerful protein-based drugs that would otherwise be too toxic.
In fact, members of the Plueckthun group are currently applying their technology in a project aimed as a therapy for Covid-19. Adenoviral vectors are already being used in several of the COVID vaccines, including the Johnson & Johnson, AstraZeneca, China’s CanSino Biologics and Russia’s Sputnik V vaccines – but without the innovative SHREAD technology. “By delivering the SHREAD treatment to patients via an inhaled aerosol, our approach could allow targeted production of Covid antibody therapies in lung cells, where they are needed most,” Smith explains. “This would reduce costs, increase accessibility of Covid therapies and also improve vaccine delivery with the inhalation approach.”
Original Article: New technology makes tumor eliminate itself
More from: University of Zurich
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
SHREAD treatment
- King Charles feels 'frustrated' amid cancer treatment
"He remains wholly positive about his treatment and looks forward to returning to full public duty as soon as possible. "His Majesty has chosen to share his diagnosis to prevent speculation and in the ...
- $163 Billion Precision Oncology Markets - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2023 & 2024-2029F
The Global Precision Oncology Market signifies a significant transformation in cancer treatment, utilizing advanced technologies and customized therapies to address cancer's complexity and diversity.
- More Patients Participate in Cancer Treatment Trials Than Previously Estimated
In addition to cancer treatment trial enrollments, Unger and colleagues estimated participation in a variety of other study types, including biorepository (12.9%), registry (7.3%), genetic (3.6%), ...
- Federal investigation alleges RI ‘warehouses’ children in psychiatric treatment
U.S. Attorney Zachary Cunha is accusing the state of Rhode Island of violating the federal civil rights of children with mental health or developmental disabilities. A multi-year federal investigation ...
- King Charles Reveals He’s Experienced a Loss of Taste as a Side Effect of His Treatment for Cancer
T oday was already going to be an emotionally loaded one for perhaps another reason—Prince William was officially named the Colonel-in-Chief of the Army Air Corps, a role that was expected to go to ...
Go deeper with Google Headlines on:
SHREAD treatment
[google_news title=”” keyword=”SHREAD treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
SHielded REtargetted ADenovirus
- Hero father who 'shielded his wife and four-year-old daughter from sword-wielding killer' is pictured for the first time - as his sister reveals how suspect 'burst into their ...
A father said to have shielded his wife and four-year-old daughter from a sword-wielding killer has been pictured for the first time. Henry De Los Rios Polania, 35, is fighting for his life in ...
- Clergy sexual abuse probe targets New Orleans Catholic Church leaders who may have shielded predators
AP The documents chronicle years of abuse claims, interviews with accused clergy and a pattern of church leaders transferring problem priests, but they have been shielded under a sweeping ...
- KiKi World raises $7m to bring blockchain to beauty
You probably recommended it to all your friends. And what do you get for that? Just more retargeted ads,” she stated. Instead, KiKi World customers can vote on beauty products designed by its ...
- Adenovirus Type 14 Acute Respiratory Disease
An unusual adenovirus, type 14, has caused several outbreaks of respiratory disease, with considerable morbidity and mortality. Many adenovirus serotypes cause disease in humans: Serotypes 2 ...
- Adenovirus grips the city
Adenovirus (ADV) has gone uncontrollable due to the climate change and environmental pollution in Karachi. Patients with ADV are visiting the hospital with symptoms of headache, chills, cough ...
Go deeper with Google Headlines on:
SHielded REtargetted ADenovirus
[google_news title=”” keyword=”SHielded REtargetted ADenovirus” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]